Search & Analyze
Popular Searches
Vilin Bio Med Ltd.
Healthcare₹40.65
CMP₹40.65
Mkt Cap₹62 Cr
P/E32.14
P/B2.54
ROE0.97%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
32.14
P/B Ratio
2.54
EV/EBITDA
20.19
Price/Sales
1.47
Dividend Yield (%)
0.00
EPS (TTM ₹)
1.26
Book Value (₹)
15.98
ROE (%)
0.97
ROCE (%)
4.16
ROA (%)
0.74
EBITDA Margin (%)
5.31
Net Profit Margin (%)
1.51
Debt/Equity
0.11
Current Ratio
2.75
Interest Coverage
1.36
Asset Turnover
0.49
Working Capital/Sales
1.85
Core EBITDA Growth (%)
10.01
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 1171.52 | 1121.49 | 1231.3 | 1580.49 | 1480.99 |
| Net Sales | 1171.52 | 1121.49 | 1231.3 | 1580.49 | 1480.99 |
| Total Income | 1174.12 | 1121.91 | 1233.74 | 1612.92 | 1527.84 |
| Total Expenditure | 1088.1 | 1044.92 | 973.99 | 1498.81 | 1402.31 |
| Operating Profit | 86.02 | 76.99 | 259.75 | 114.11 | 125.53 |
| Depreciation | 25.7 | 21.92 | 16.76 | 13.01 | 10.44 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 16.11 | 4.47 | 178.15 | 22.52 | 30.58 |
| Tax | 3.98 | 1.11 | 53.65 | 6.28 | 8.23 |
| Profit After Tax (PAT) | 12.13 | 3.36 | 124.5 | 16.24 | 22.35 |
| EPS (₹) | 0.37 | 0.1 | 1.25 | 0.12 | 0.16 |
| Dividend Payout % | — | — | — | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 330 | 330 | 995 | 1395 | 1395 |
| Reserves | 406.26 | 409.62 | 72.76 | 889 | 911.35 |
| Shareholders Funds | 736.26 | 739.62 | 1067.76 | 2284 | 2306.35 |
| Total Debt | 551.58 | 529.96 | 493.12 | 682.99 | 257.33 |
| Total Liabilities | 1389.14 | 1355.84 | 1767.58 | 3240.39 | 2772.79 |
| Total Assets | 1389.14 | 1355.84 | 1767.58 | 3240.39 | 2772.79 |
| Book Value / Share | 22.3109 | 22.4127 | 10.7313 | 16.3728 | 16.533 |
| Assets | 1389.14 | 1355.84 | 1767.58 | 3240.39 | 2772.79 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | -100.18 | 20.87 | -165.85 | -742.1 | 21.75 |
| Investing Activities | — | — | -2.95 | 32.3 | -110.91 |
| Financing Activities | 98.17 | -21.62 | 168.35 | 887.05 | -510.17 |
| Net Cash Flow | -2.01 | -0.75 | -0.45 | 177.25 | -599.33 |
VILINBIO
₹40.65
+0%